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Abstract
Objective: Gut microbiota are linked to metabolic function, body weight regulation,
and brain and behavioral changes. Alteration of gut microbiota is repeatedly demon-
strated in adults with anorexia nervosa (AN) and transplantation of stool from adult
patients with AN reduces weight gain, food consumption and food efficiency in
germ-free mice. No similar data are available for adolescents, who might differ from
adults due to their shorter duration of illness.
Method: Nineteen female adolescent patients with AN at admission and after short-term
weight recovery were included in a longitudinal study and compared to 20 healthy controls
(HC). DNA was extracted from stool samples and subjected to 16S rRNA gene sequencing
and analysis. Group comparisons, indicator genera and simper analysis were applied. Taxon
abundances at admission was used to predict inpatient treatment duration.
Results: Alpha diversity is increased in patients with AN after short-term weight recov-
ery, while beta diversity shows clear group differences with HC before and after
weight gain. A reduction in Romboutsia and taxa belonging to Enterobacteriaceae at
both timepoints and an increase in taxa belonging to Lachnospiraceae at discharge are
most indicative of patients. Lachnospiraceae abundance at admission helped to predict
shorter inpatient treatment duration.
Discussion: This pilot study provides first evidence of gut microbiota alterations in
adolescent patients with AN that do not normalize with weight gain. If verified in
larger studies, the predictive power of taxa belonging to Lachnospiraceae for clinical
outcome could complement known predictors at admission, inform clinicians and
serve as a target for nutritional interventions.
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1 | INTRODUCTION
There is a fast growing body of literature demonstrating the important
role of gut microbiota in metabolic processes, regulating body weight
(Harmsen & de Goffau, 2016; Thaiss, Zmora, Levy, & Elinav, 2016)
and influencing brain function and behavior via the gut-brain axis
(Cryan et al., 2019). These processes are obviously affected in
anorexia nervosa (AN) and thus motivate further exploration of the
role of microbiota in the etiology, maintaining factors and weight
rehabilitation of AN (Bulik, Flatt, Abbaspour, & Carroll, 2019; Mack
et al., 2018).
The gut microbiota consists of bacteria, archaea, viruses, and
fungi living in the gut and forming complex communities. While diet is
one of the main influencing factors on the gut community, microbiota
are in turn an important influencing factor on body weight and vary in
patients with obesity, normal weight and underweight (Bai, Hu, &
Bruner, 2019). Stool transplantations from obese patients into germ-
free mice (gf-mice) can lead to an increase in weight, which is associ-
ated with the capability to extract more energy from the same amount
of food (Ridaura et al., 2013). Stool from malnourished patients
showed the opposite effect. Gut microbiota are implicated not only in
inflammatory processes and diseases such as inflammatory bowel dis-
eases, diabetes and arthritis (Bravo-Blas, Wessel, & Milling, 2016;
Miyoshi & Chang, 2017; Tilg & Moschen, 2014), but also in psychiatric
diseases such as depression and anxiety (Luna & Foster, 2015). Kelly
et al. (2016), for example, showed that stool transplantation from
depressed patients into gf-mice can transfer a depressive phenotype.
In a first transplantation study with stool from adult patients with
AN into gf mice, Hata et al. showed a causal effect of the gut micro-
biota for at least the maintenance of AN. The offspring of transplanted
animals displayed a decrease in body weight gain, food intake and food
efficiency ratio (body weight gain/food intake). They also had reduced
serotonin concentrations in the brain stem and showed an increase in
anxiety and obsessive behavior (Hata et al., 2019).
Six cross-sectional studies exploring the gut microbiota in AN
with 9–33 adult patients and comparing AN with HC have been publi-
shed to date (Armougom, Henry, Vialettes, Raccah, & Raoult, 2009;
Borgo et al., 2017; Hanachi et al., 2019; M. Million et al., 2013; Morita
et al., 2015; Mörkl et al., 2017), while three longitudinal studies with
3–44 patients have been performed (Kleiman, Watson, et al., 2015;
Kleiman et al., 2017; Mack et al., 2016), of which only Mack et al. had
a mixed adolescent/adult sample.
The preliminary results of these studies vary considerably
(Kleiman, Carroll, Tarantino, & Bulik, 2015; Mack et al., 2018; Seitz,
Trinh, & Herpertz-Dahlmann, 2019). Some studies found reduced bac-
terial diversity in patients with AN (Kleiman, Watson, et al., 2015;
Mörkl et al., 2017), while others did not (Borgo et al., 2017; Mack
et al., 2016). Several alterations in the taxa abundances were noted
during the acute state (Borgo et al., 2017; Kleiman, Watson,
et al., 2015; Mack et al., 2016). It is currently unclear how these alter-
ations impact the course of AN and whether they can be potentially
used to help predict (short-term) disease outcome. Importantly, both
Kleiman and Mack found evidence of significantly altered microbiota
after short-term weight recovery in their mostly chronically ill adult
and mixed adult/adolescent samples, again emphasizing that altered
microbiota are not simply epiphenomena of undernutrition (Kleiman,
Watson, et al., 2015; Mack et al., 2016). However, it remains unclear
whether this also applies to adolescent patients as they are less often
chronically ill, and microbiota alterations may not become as ingrained
as those in adults with a generally longer duration of illness.
Finding altered microbiota in patients with AN and especially iden-
tifying those associated with a positive outcome could lead to new
intervention targets. These taxa could be isolated, cultivated and
administered as probiotics or alternatively, nutritional or prebiotics indi-
rectly fostering their growth could be tested to supplement current
refeeding practices in AN. There is growing evidence for the effect of
these interventions in other psychiatric or “weight regulation” disorders
such as obesity or underweight (Depommier et al., 2019; Matthieu Mil-
lion, Lagier, & Raoult, 2017; Pirbaglou et al., 2016; Trehan et al., 2013).
We thus decided to compare gut microbiota diversity and taxon abun-
dances in a longitudinal sample of adolescent patients with AN and
compare them to those of age-matched HC. We hypothesized that the
microbiota of adolescents with AN—corresponding to the results in
adults—differ from that of HC and do not normalize with weight recov-
ery, despite the younger age, shorter illness duration in most cases and
age-dependent different hormonal status. We furthermore hypothe-
sized that the abundance of certain taxa at admission could help predict
duration of inpatient treatment.
2 | METHOD
2.1 | Patients and controls
Twenty-two consecutive patients were initially recruited at the Uni-
versity Hospital Aachen and enrolled between November 2016 and
January 2018. The time points measured were admission to inpatient
hospital treatment and discharge to outpatient care on average
4 months later. Three patients were prescribed antibiotics between
admission and discharge and were excluded from the analysis, leaving
19 patients to be analyzed. Additionally, 20 age-matched healthy
female controls (HC) were enrolled using newspaper advertisements.
The inclusion criteria were as follows: diagnosis of AN according
to DSM 5, female sex, and age between 12 and 18 years. The exclu-
sion criteria were as follows: use of antibiotics or probiotics within
4 weeks before enrollment, IQ < 85, insufficient knowledge of Ger-
man language, severe other mental disorder and severe gastrointesti-
nal or metabolic illnesses such as celiac disease or diabetes mellitus.
The same exclusion criteria were also applied for the healthy volun-
teers in addition to having a high or low bodyweight (>80th or <20th
age adjusted percentile of body mass index [BMI-SDS]), any current
psychiatric illness and any lifetime eating disorder. All participants and
their legal guardians gave written informed consent prior to enroll-
ment. The agreement of the local ethics committee of the University
of RWTH Aachen was obtained for this study, and the study was con-
ducted in accordance with the Declaration of Helsinki.
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Clinical data including body weight after an overnight fast mea-
sured in BMI and BMI-SDS calculated using Ped(z) calculator with
KiGGS Data (Schaffrath, 2003) at admission and discharge were noted
as well as BMI prior to the illness, weight loss prior to admission, ill-
ness duration, weight gain during treatment and the duration of treat-
ment. Any medication use at admission was noted and sorted into the
following groups to be each used as a binary covariate: laxatives, anti-
biotics, antidepressants, gastrointestinal medications, others.
Patients received treatment as usual that included weight rehabil-
itation, individual and group psychotherapy, parent psychoeducation
and training, occupational-, music- and physical therapy. Nutritional
therapy started with 1,200 kcal/day and was augmented every sec-
ond day by 200 kcal/day until weight increased by 500–1,000 g/week
up to the 20th–25th age adapted BMI-percentile.
2.2 | Questionnaires and interviews:
Each participant in the study completed three questionnaires at admis-
sion and discharge: The Eating Disorder Inventory 2 (EDI), Beck Depres-
sion Inventory (BDI) and Spence Children's Anxiety Scale (SCAS) (Beck,
Steer, Ball, & Ranieri, 1996; Garner & Olmsted, 1986; Spence, 1998).
Patients also received the semi-structured eating disorder interview
EDE (Eating disorder Examination, first German edition 2016) (Cooper,
Cooper, & Fairburn, 1989; Luce & Crowther, 1999).
2.3 | Fecal sample collection and DNA extraction:
Fecal samples were collected by the patients within 2 weeks of admis-
sion and at discharge using a single-use paper stool catcher (The Feces
Catcher, Tag Hemi VOF, Netherlands) by transferring a pea-sized sam-
ple from two different sites of the stool into a sterile plastic container.
The stool samples were stored at −80C until further use. Time
between stool sampling and symptom report was kept to a minimum
and averaged 4.1 days.
Healthy volunteers were instructed to collect their stool at home
using the same procedure and bring or send the samples to the clinic
to be frozen at −80C until further use. All samples were then sent on
dry ice to JB and MB for analysis.
To extract DNA from stool samples, we used the DNeasy Power
Soil Kit (Qiagen) following the manufacturer's instructions and
matching procedures of the Human Microbiome Project (The Human
Microbiome Project Consortium, 2012).
2.4 | 16S rRNA gene sequencing and processing
We sequenced the V1-V2 region of the 16S rRNA gene using primers
27F and 338R consistent with the Human Microbiome Project and pre-
vious works of our group (Claussen et al., 2017). We followed a dual
barcoding approach whereby forward and reverse primers contained a
unique eight base multiplex identifier to tag PCR products.
During demultiplexing, no mismatch in the barcode was allowed
(Casava, Illumina). Forward and reverse reads were merged in Usearch
(v.7) (Edgar, 2010) as follows: reads were truncated at the first base
where the quality score dropped below Q = 3, the maximum number of
mismatches in the overlap region was 2, the minimum length of reads
after truncation was 200 bp, the minimum length of the overlap region
was 150 bp, the minimum length of the merged read was 270 bp, and
the maximum length of the merged read was 330 bp. Next, merged
reads were filtered using the expected error parameter E = 0.1. Chime-
ric sequences were removed in Uchime using the Silva Gold reference
database (Edgar, Haas, Clemente, Quince, & Knight, 2011).
RDP Multi-Classifier version (v.9.0) (Wang, Garrity, Tiedje, &
Cole, 2007), as implemented in Mothur (v.31) (Schloss et al., 2009), was
used to assign taxonomy using a confidence threshold of 0.80 and 1,000
iterations. Sequences classified as eukaryotic, unknown, or mitochondrial
were removed. Sequences were aligned to the Silva reference database
(Pruesse et al., 2007), and those that did not align were removed. Aligned
sequences were denoised using the “pre-cluster” algorithm in Mothur.
Prior to OTU binning, sequences were rarefied to 10,000 reads per sam-
ple. OTUs were binned at a 97% similarity threshold using distance-
based greedy clustering (dgc) implemented in Mothur.
2.5 | Statistics
2.5.1 | Group comparisons of microbiota data
All statistical analyses were carried out in R (v.3.6.1) (R Core Team,
2019). Comparison of core taxon abundances (defined as present in at
least 25% of the individuals, with at least 1% relative abundance) was
performed using the Mann–Whitney U and Wilcoxon signed rank
tests, and p values corrected for multiple testing according to Ben-
jamini and Hochberg (1995). As effect size measure, we report r (see
Mangiafico, 2016), which is defined as the Z value from the test
divided by the total number of observations (Mann–Whitney U-test)
or by the number of samples (Wilcoxon signed Rank test), on a scale
of 0 to 1, with values of >0.5 usually considered a large effect.
To identify taxa that contribute to the disparities in microbiota
composition across treatment groups (patients at admission n = 19,
patients at discharge n = 19, and healthy controls n = 20), we per-
formed (a) indicator taxa analyses in the “indicspecies” R package
(De Cáceres & Legendre, 2009) using the “r.g” function (Cáceres,
Legendre, & Moretti, 2010) and 105 permutations and (b) “simper”
analysis in the “vegan” R package (v.1.7.9) (Oksanen, 2007) with 105
permutations. For the indicator taxa analysis, the “effect size”
parameter indicates the strength of the association on a scale of 0 to
1 (parameter “stat” of r.g function), with higher values indicating a
stronger association. For the simper analysis, the reported “contribu-
tion” value is an estimator of each genus' contribution to discriminat-
ing the groups (parameter “average” of simper function) and
therefore can be used to quantify the strength of the effect, again,
with higher values indicating a stronger contribution to
discrimination.
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Alpha diversity indices (within sample diversity) were calculated
based on the lower OTU-species level with the scope of revealing
potential disparities in distribution patterns across treatment groups that
we might not detect at the phylum and genus levels using “diversity”
and “estimateR” in the “vegan” (v.2.5-6) R package and compared
across individual groups as mentioned above. Additionally, we assessed
individual diversity (beta diversity) at the OTU-species level using Bray-
Curtis and Jaccard indices, which are based on disparities in taxon abun-
dances and presence/absence, respectively, and evaluated the influence
of the individual groups using PERMANOVA “adonis” and constrained
principal coordinates analyses with 105 permutations in “vegan.”
To assess associations with clinical parameters, we calculated
Spearman correlations between alpha-diversity at admission, dis-
charge and the difference between both time-points with respective
values of BMI-SDS, BDI, SCAS, and EDE as well as with illness dura-
tion and prior weight loss.
2.5.2 | Prediction analysis: Effect of the gut
microbiota at admission on the duration of treatment
The duration of treatment and not BMI-SDS at discharge was selected
as the clinical outcome parameter, due to the target weight being
fixed at the 20th to 25th age-adjusted BMI percentile and thus con-
taining only limited variance. To control for known predictors of clini-
cal outcome and inpatient treatment duration, we first constructed a
linear model with duration of treatment as the dependent variable
and weight loss prior to treatment (BMI-SDS), illness duration and
absolute weight at admission (BMI-SDS) as explanatory variables.
Next, we built a second linear model that included the residuals of the
first linear model as the dependent variables and the relative abun-
dance of the microbial trait as an explanatory variable for each of the
core genera, together with medication use, with the different medica-
tion groups as binary covariates.
To check the models, we (a) inspected the distribution of the
residuals, (b) plotted the residual versus fitted values, and
(c) examined the residual distribution across the explanatory variables
included in the models. If needed, square root transformation of
microbial relative abundances was used to correct for non-normal
distribution.
3 | RESULTS
For the clinical characterization of patients at admission and dis-
charge, please see Table 1.
TABLE 1 Clinical sample characteristics
AN admission AN discharge HC
n = 19 n = 19 n = 20
Age (years) 15.77 (1.94) [12.01;18.63] 16.16 (1.99) [12.24;18.99] 16.35 (1.11) [14.31;17.89]
BMI (kg/m2) 15.76 (2.03) [13.04;18.88] 18.8 (0.87) [16.84;20.11] 20.31 (2 .35) [17.04;25.32]
%EBW 75.13 (10.25) [60.1;91.58] 79.82 (3.9) [79.82;95.83] 94.77 (10.31) [81.34;116.66]
BMI-SDS (z-score) −3.08 (2.07) [−6.78;-0.59] −0.97 (0.42) [−2.16;0.28] −0.51 (0.82) [−1.86;0.94]
BMI prior to admission (kg/m2) 20,2 (2,72) [15,5;26,6]
Premorbid body weight (BMI) 4.44 (3.09)
[1;13.09]
Weight loss prior to admission (BMI-SDS) 2.73 (2.02) [0.61;7.52]
Illness duration (month) 17.16 (16.12) [3;62]
Weight gain during therapy (BMI) 3.17 (2.07) [0.77;7.84]
Weight gain during therapy (BMI-SDS) 2.11 (1.92) [0.31;5.47]
Therapy duration (month) 4.05 (1.39) [2;7]
EDI 2 total score 295.16 (50.69) [168;372] 270.26 (68.28) [146;415] 183.15 (36.59) [123;236]
BDI 2 score 22.68 (19.95) [0;41] 17.00 (15.75) [0;54] 5.65 (4.87) [0;17]
SCAS total score 28.271 (14.79) [2;67] 19.74 (17.08) [0;75] 17.85 (9.61) [4;39]
EDE total score 4.50 (1.19) [1.35;5.76] 2.82 (1.49) [0.43;5.38]
Atypical AN N = 2 (10.5%)
Binge/purge subtype N = 1 (5.3%)
Note: Values are depicted as the mean, standard deviation in brackets and minimum and maximum values in square brackets. p-values are calculated
between AN at admission versus AN at discharge.
Abbreviations: AN, Anorexia Nervosa; BDI, Beck Depression Inventory; BMI-SDS, Body mass index—standard deviation scores; EDE, Eating Disorder
Examination; EDI, Eating Disorder Inventory; HC, Healthy Controls; SCAS, Spence Children's Anxiety Scale; %EBW: Percent expected body weight.
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3.1 | Differences in core phylum abundances
between patients and HC
When inspecting the abundances of the core phyla (Figure 1a and
Figure S1a), we find Firmicutes to significantly increase with weight
gain (adjusted p-value .002, effect size r = 0.69) to a significantly
higher level in patients at discharge versus HC (adjusted p-value
.0005, effect size r = 0.56; see Table 2A for results on all core
phyla).
3.2 | Patterns of core genera across patients
and HC
First, in pairwise comparisons we found Anaerostipes to be increased
in patients at admission versus HC, while Romboutsia and on a trend
level unclassified Enterobacteriaceae are reduced (adjusted p-values:
.012, .008, and .058, effect sizes r = 0.46, 0.48, and 0.38, respectively;
Figure 1b). Significant increases following weight gain are found for
Fusicatenibacter, Lachnospiracea, Ruminococcaceae, and
Faecalibacterium while Bacteroides decrease between admission and
discharge (adjusted p-values .022, .0008, .007, .032; .001, r = 0.39–
0.74). At discharge, Romboutsia and on the trend level unclassified
Enterobacteriaceae remain decreased in patients, while
Fusicatenibacter and unclassified Lachnospiraceae are newly increased
in patients compared to HC (adjusted p-values: .044, .059, .022, and
3.50 × 10−5, r = 0.33–0.71, see Table 2B for results on all core genera).
Second, we performed indicator taxa analyses, which examines the
affinity or preference of a given taxon to one- or a combination of
defined environments. These analyses reveal unclassified
Enterobacteriaceae and Romboutsia to be associated to healthy controls
(effect size = 0.40, p = .03; effect size = 0.33, p = .09, respectively),
while unclassified Lachnospiraceae is strongly associated with patients
at discharge (effect size = 0.61, p = .0001; Figure 1c, Table S1).
F IGURE 1 Mean relative abundance of core phyla (a), and genera (b) and indicator genera (c) in disease and healthy states. Samples from
patients with AN at hospital admission (n = 19) and discharge (n = 19) and HC (n = 20) at the (a) phylum and (b) genus taxonomic levels. Core
samples were defined as present in at least 25% of the individuals with at least 1% relative abundance. Comparisons between AN and HC:
Mann–Whitney U test with *p < .05, **p < .01, ***p < .001. Longitudinal comparisons Wilcoxon signed rank test with #p < .05, ##p < .01,
###p < .001. (c) Box plots of the relative abundance of significant indicator genera defining (i) patients at discharge or (ii-iii-C) typical for HC (i) Un.
Lachnospiraceae, (ii) Un. Enterobacteriaceae and (iii) Romboutsia. *p < .05 AN, anorexia nervosa; HC, healthy controls [Color figure can be viewed
at wileyonlinelibrary.com]
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AN admission versus AN
discharge p-value
Effect size r Effect size r Effect size r
Panel A: Phylum
Bacteroidetes 46.70 52.03 39.03 .34 .13 .044
r = 0.155 r = 0.274 r = 0.564
Firmicutes 34.91 39.58 51.43 .15 .0005 .002
r = 0.234 r = 0.576 r = 0.693
Proteobacteria 15.98 4.48 8.21 .09 .13 .86
r = 0.346 r = 0.274 r = 0.0461
Unclassified 1.22 2.05 0.68 .83 .33 .099
r = 0.036 r = 0.199 r = 0.493
Panel B: Genus
Bacteroides 31.19 41.44 28.54 .19 .55 .0013
r = 0.248 r = 0.099 r = 0.748
Unclassified
Enterobacteriaceae
9.27 0.58 3.05 .059 .06 .87
r = 0.376 r = 0.331 r = 0.0369
Un. Ruminococcaceae 4.53 4.53 8.42 .9 .12 .0072
r = 0.0226 r = 0.282 r = 0.665
Un. Lachnospiraceae 4.38 6.09 10.19 .13 .00004 .0008
r = 0.248 r = 0.705 r = 0.739
Blautia 3.51 3.63 4.74 .43 .1 .1
r = 0.128 r = 0.315 r = 0.415
Faecalibacterium 3.37 2.96 4.93 .46 .46 .032
r = 0.122 r = 0.153 r = 0.574
Alistipes 2.86 2.95 2.20 .52 .48 .47
r = 0.106 r = 0.162 r = 0.333
Parabacteroides 2.78 2.83 1.85 .47 .14 .12
r = 0.119 r = 0.271 r = 0.484
Romboutsia 2.77 0.73 0.97 .008 .044 .4
r = 0.482 r = 0.351 r = 0.203
Un. Clostridiales 2.32 2.61 2.02 .97 .97 .97
r = 0.009 r = 0.0179 r = 0.0369
Un. Erysipelotrichaceae 2.17 2.28 2.61 .76 .76 .76
r = 0.0562 r = 0.171 r = 0.0739
Anaerostipes 1.83 3.28 2.36 .012 .19 .19
r = 0.461 r = 0.213 r = 0.351
Barnesiella 1.40 0.81 1.26. .97 .97 .77
r = 0.0701 r = 0.00908 r = 0.266
Un. Bacteria 1.22 2.05 0.68 .83 .33 .099
r = 0.036 r = 0.1999 r = 0.493
Fusicatenibacter 1.05 1.01 1.83 .45 .023 .023
r = 0.124 r = 0.388 r = 0.583
Oscillibacter 0.99 1.71 2.19 .36 .36 .98
r = 0.216 r = 0.191 r = 0.00461
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Finally, we applied a “simper” analysis to identify taxa that dis-
criminate between patients and HC. We find that Anaerostipes signifi-
cantly contributes to differentiating patients at admission and HC
(contribution = 2%, p = .025), whereas the abundances of unclassified
Lachnospiraceae, unclassified Enterobacteriaceae, unclassified
Ruminococcaceae and Barnesiella differentiate between patients at
discharge and HC (4%, 6%, 4%, p < .05, respectively; Figure S2 and
Table S2).
3.3 | Alpha and beta diversity
We observe no difference between patients with AN at admission
and HC in any of the alpha-diversity measures calculated on the
most sensitive OTU level, which measures diversity within sub-
jects. However, during weight gain, alpha diversity increases
significantly and when comparing AN at discharge with HC, we












AN admission versus AN
discharge p-value
Effect size r Effect size r Effect size r
Un.Clostridium
sensu_stricto
0.87 1.75 1.09 .91 .52 .45
r = 0.0202 r = 0.153 r = 0.335
Note: Results of Mann–Whitney-U, Wilcoxon signed rank tests and effect sizes between patients with AN and HC of all (A) core phylae and (B) core
genera. Core phylae and genera were defined as being present in at least 25% of the sample with at least 1% relative abundance. Abundances of healthy
controls, patients at admission and patients at discharge and corresponding corrected p-values are shown. Significant effects (p < .05) are marked in bold.
Effect size calculation: As effect size measure, we report r (see for example, Mangiafico, 2016), which is defined as the Z value from the test divided by the
total number of observations (Mann-Whitney U-test) or by the number of samples (Wilcoxon signed Rank test), on a scale of 0 to 1, with values of >.5
usually considered high effect sizes.
Abbreviations: Un., unclassified; corr., corrected (Benjamini & Hochberg, 1995).
F IGURE 2 Alpha and beta diversity measures. Alpha and beta diversity based on species-level OTUs in samples from patients with AN at
hospital admission (n = 19) and discharge (n = 19) and HC (n = 20). (a) Alpha diversity (richness) was characterized by the number of observed
bacterial species in each sample, the Shannon index and the Chao1 estimator of diversity. Differences in alpha diversity were calculated using the
two-sided Wilcoxon pairwise run sum test. (b) Beta diversity was assessed by the Bray-Curtis and Jaccard indices and tested using PERMANOVA
“adonis” and constrained principal coordinates analyses with 105 permutations in “vegan”. Comparisons between AN and HC: Mann–Whitney
U test with *p < .05, **p < .01, ***p < .001. Longitudinal comparisons Wilcoxon signed rank test with #p < .05, ##p < .01, ###p < .001. AN, anorexia
nervosa; HC, healthy controls; OTU, operational taxonomic units [Color figure can be viewed at wileyonlinelibrary.com]
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index in the patient group (p = .028 and p = .035, respectively,
Figure 2a).
The (between groups) beta diversity comparison on the OTU level
reveals significant differences between patients and HC based on the
Bray-Curtis and Jaccard indices (Bray-Curtis, PERMANOVA,
R2 = 0.05, p = .02, constrained principal coordinate analyses, con-
strained inertia = 0.05, p = .02; Jaccard, PERMANOVA, R2 = 0.04,
p = .007, constrained principal coordinate analyses, constrained iner-
tia = 0.04, p = .005). These differences do not normalize upon weight
gain, showing clear differences between the community structures of
patients with AN at discharge (Figure 2b).
We found no correlations between alpha diversity measures and
clinical parameters.
3.4 | Predictive effect of the gut microbiota at
admission on the duration of treatment
To investigate the potential influence of individual core taxon abun-
dances in patients at admission on the duration of treatment, we used
a linear model approach to first correct for the influence of duration
of illness, prior weight loss and BMI-SDS at admission. This yielded a
model explaining 18% of the variance in duration of treatment (F-sta-
tistic: 2.33 on 3 and 15 DF, p = .11, R2 = 18%).
Next, we evaluated each of the core genera for an added predic-
tive effect. We find that a higher abundance of unclassified
Lachnospiraceae in patients at admission is associated with a shorter
duration of treatment (F-statistic: 4.86 on 1 and 17 DF, p-value: .04,
Beta coefficient value: −0.90), explaining an additional 18% of the
variance of duration of treatment (Figure 3). Interestingly, GI medica-
tion also displays a trend-level significant effect on predicting the
duration of treatment (F-statistic: 3.25 on 1 and 17 DF, p-value = .089),
explaining 11% of the variance. Jointly with GI tract medication,
Lachnospiraceae explains 21% of the residual variation in inpatient
treatment duration (whole model: F-statistic, 3.43 on 2 and 16 DF,
p = .05; Lachnospiraceae, beta coefficient = −0.74, p = .03, GI-medica-
tion beta coefficient = −0.086, p = .08), thus correcting for GI medica-
tion use at admission.
4 | DISCUSSION
The goal of this study was to provide a first assessment of the gut
microbiota in adolescents with AN, given the differences previously
observed in adults with the disease. We further examined whether
the differences between AN versus HC adolescents revert after
weight recovery, and whether microbiota help to predict the duration
of treatment. Our adolescent patients indeed display marked differ-
ences compared to HC in this pilot study. Further, weight-recovered
patients still harbor distinct differences in their gut microbiota,
supporting the hypothesis that our observations in adolescent AN are
more than just a weight-related epiphenomenon, despite a shorter
duration of illness of on average 17 months. Interestingly, this
dysbiosis in adolescents appears to be different compared to that in
adults regarding overall community patterns and the types of individ-
ual taxa involved. Furthermore, we find a higher abundance of taxa
belonging to Lachnospiraceae to predict a shorter inpatient treatment
duration independent of illness duration, prior weight loss and abso-
lute low weight at admission.
The gut microbial patterns in adolescent AN at admission are char-
acterized in the indicator analysis and group comparison by a reduction
in Romboutsia and taxa belonging to Enterobacteriaceae, which remain
present after weight recovery, following on average 4 months of treat-
ment. Further, unclassified Lachnospiraceae significantly increased to
higher levels than that of HC, despite weight rehabilitation. Addition-
ally, the absolute number of species found in patients at discharge was
significantly higher than that of HC. Thus, similar to adults with AN
(Kleiman et al., 2017; Kleiman, Watson, et al., 2015; Mack et al., 2016),
change of the microbiota in adolescents with AN is not simply a func-
tion of weight loss and does not disappear upon (short-term) weight
restoration. This is compatible with the notion that, comparable to
adults, microbiota could play an important role in the pathophysiology
of AN. To further test this hypothesis, longer-term follow-up studies
are needed in adolescent (and adult) patients. Future studies should
analyze whether these differences after short-term weight recovery
only occur during a temporary adjustment period, are associated with
still-altered feeding behavior commonly found in AN (Tomba, Tecuta,
Crocetti, Squarcio, & Tomei, 2019) or persist after long-term recovery
and are thus are trait markers of the disease.
Interestingly, there are also several differences in adolescent -
compared to adult patients with AN, especially regarding the
F IGURE 3 Lachnospiracea predicting inpatient treatment
duration. Results of the second linear model including relative
abundance of unclassified Lachnospiraceae predicting inpatient
treatment duration corrected for duration of illness, prior weight loss
and low BMI-SDS at admission. F-statistic, 4.86 on 1 and 17 DF;
p-value, .04; Beta coefficient value, −0.90
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intraindividual alpha diversity and the specific phyla and genera
involved. While the overall number of species in prior studies of adult
patients with AN was found to be either reduced (Kleiman, Watson,
et al., 2015; Mörkl et al., 2017) or unaltered (Hanachi et al., 2019;
Mack et al., 2016), we did not find any alterations in adolescents at
admission. In contrast, after weight recovery, we even found an
increased alpha diversity, a finding that was only shared by Mack
et al., the single previous study involving a mixed sample of both
44 adults and 11 adolescents (Mack et al., 2016). This increase could
reflect a temporary adjustment to weight rehabilitation, be nutrition-
related or represent a specific marker in adolescent AN A similar pic-
ture was observed among genera. Anaerostipes (family of
Lachnospiraceae) were significantly increased at admission compared
to HC and non-significantly increased at discharge by 50%. This con-
trasted with the finding that the abundance of Anaerostipes was
reduced in adults with AN (Hanachi et al., 2019; Kleiman, Watson,
et al., 2015) but fits well with the finding of Mack et al. in their sample
also comprising 11 adolescents, who found that the abundance of
Anaerostipes significantly increased both before and after weight reha-
bilitation. Decreased Romboutsia and unclassified Enterobacteriaceae
at admission and discharge, while underscoring persistent differences
in adolescent AN even after weight recovery, contrasts to the finding
of Borgo et al., who observed increased Enterobacteriaceae at admis-
sion in adults. Moreover, to our knowledge the increase in unclassified
Lachnospiraceae and Fusicatenibacter at discharge found in our study
was not observed in any adult studies to date. Differences in the AN-
associated gut microbiota between adolescents and adults could be
caused by multiple factors. While the gut microbiota generally
changes with age, this takes place most notably at the beginning and
end of life; birth mode, breast feeding and early nutrition play impor-
tant roles at the beginning of life, and chronic illnesses and medication
use as well as nutrition and physical activity play important roles at
the end (Galazzo et al., 2020; Takagi et al., 2019). However, adoles-
cents still undergoing development, especially due to their hormonal
changes during puberty, do show some age-specific alterations in
their gut microbiota compared to adults (Farzi, Fröhlich, &
Holzer, 2018). Additionally, adolescents differ from adults in their
feeding patterns, physical activity and number of past infections and
medication use, all known to have important effects on the gut
microbiota.
Mechanisms of the gut microbiota's interaction with the host in
AN include less energy harvest from the same food, making weight
rehabilitation even more difficult (Aurigemma, Koltun, VanEvery, Rog-
ers, & De Souza, 2018; Seitz, Belheouane, et al., 2019). Microbiota
also exert regulatory effects on gut wall permeability (Karl
et al., 2017). Higher gut permeability can allow more bacteria and
their products to traverse the gut wall and enter cells and the blood-
stream, leading to inflammation and (auto-) immune processes
(Nagpal & Yadav, 2017). Interestingly, a higher rate of autoimmune
diseases is found in AN, as well as low-grade inflammation particularly
in the GI tract, including an up to fourfold increased risk of inflamma-
tory bowel diseases, the causes of which remain poorly understood
(Hedman et al., 2019; Raevuori et al., 2014). These observations are
hypothesized to be associated with increased intestinal permeability
in AN (Jésus et al., 2014; Seitz, Belheouane, et al., 2019), but more
research is needed. Inflammation is also linked to anxiety, obsessive-
ness and depression (Li et al., 2019), the three major comorbidities in
patients with AN (Herpertz-Dahlmann, Seitz, & Baines, 2017). We did
not find any significant associations with anxiety, depressiveness or
eating disorder pathology in our sample, potentially due to the small
sample size. To disentangle initiating factors from maintaining factors,
as well as the effects of illness duration from those of age, transplan-
tation studies into gf-rodents need to be undertaken with adolescent
(and adult) donors and illness durations.
Special interest lies in the potential for microbial traits to help
predict short-term clinical outcome. We found yet unclassified taxa
belonging to Lachnospiraceae to be an interesting candidate, as an
increase in their abundance at admission helped to predict a shorter
inpatient treatment duration, which is generally associated with a bet-
ter long-term outcome (Grimaldi et al., 2018). This finding is indepen-
dent of other known predictors of shorter inpatient treatment
duration, such as prior weight loss, illness duration and low body
weight at admission. Lachnospiraceae, belonging to the phylum
Firmicutes, is one of the most common families in the human gut and
is known to decompose otherwise indigestible parts of our food. Thus,
it could conceivably play a role in increasing energy utilization in
patients with AN. In fact, Lachnospiraceae were shown to be associ-
ated with weight gain following antibiotic treatment (Liu et al., 2019)
and to increase blood glucose levels (Kameyama & Itoh, 2014). A
decrease in Lachnospiraceae is also a hallmark of several inflammatory
disorders (Geirnaert et al., 2017; Maukonen et al., 2015) and many
Lachnospiraceae species produce butyrate (Vital, Karch, &
Pieper, 2017), which is crucial to maintaining intestinal barrier func-
tion (Bordoni et al., 2019) and helping to limit the colonic inflamma-
tory response (Lobionda, Sittipo, Kwon, & Lee, 2019). As noted,
patients with AN show chronic low-grade inflammation of unknown
origin (Dalton et al., 2018) and an increased rate of autoimmune dis-
eases (Hedman et al., 2019; Raevuori et al., 2014). Thus, the anti-
inflammatory effects of Lachnospiraceae might also play a role in its
association with shorter inpatient treatment duration. Specific taxa
belonging to Lachnospiraceae associated with a positive outcome
need to be identified, extracted and cultivated to allow for supple-
mentation studies (first in animals). This would help to further eluci-
date the underlying pathomechanisms and the causality of their
impact on weight, inflammation, and behavior. The general potential
of microbiota to help to increase weight gain has already been shown
several times, for example, in stool transfer studies into mice (Ridaura
et al., 2013; Tremaroli et al., 2015). As already mentioned above, Lac-
tobacillus and Bifidobacterium probiotics have shown an effect regard-
ing anxiety or depression (Pirbaglou et al., 2016), and omega-3 fatty
acids have an impact on gut microbiota, gut wall and the immune sys-
tem (Costantini, Molinari, Farinon, & Merendino, 2017).
Limitations: First, our sample size was small, despite this study
being the second largest longitudinal study to date. Nevertheless, our
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results need to be validated in larger studies. Second, HC data was
not assessed at follow-up to control for a change of diet or other
environmental factors. Third, we did not control for the type of diet,
although this is known as an important influential factor including
the inherently larger quantities consumed by patients at discharge
compared to admission. Fourth, differences in analysis protocols,
such as the choice of 16S rRNA gene primers (e.g., we used V1-V2
compared to others that used V3-V4), can introduce biases in some
individual bacterial taxa, which may in part explain the heterogeneity
in findings between studies. However, by comparing the
microbiomes across different animal taxa, recent studies also demon-
strated that biological variables, such as the host species, prevail
over such technical aspects when the overall pattern of beta diver-
sity is considered (Rausch et al., 2019). Fifth, samples could be only
acquired during a time span of the first 2 weeks, because it took time
to convince the participants and to obtain third party consent. More-
over, many patients had a chronic obstipation and a reduced stool
production. Thus, some changes in the microbiota might have
occurred. However, patients gained on average only 0.636 kg until
sampling, so we expect our analysis to still reflect most effects of
being underweight.
5 | CONCLUSION
This is the first study of the gut microbiota in a purely adolescent sam-
ple of patients with AN.
In this pilot study, we confirmed a marked alteration of micro-
biota that persisted after weight recovery. These findings fit well with
adult findings and support an important role of microbial alterations
also in adolescents, despite their shorter duration of illness. However,
the microbial patterns present in adolescent patients appeared some-
what different to those in adults, especially regarding diversity and
the specific taxa involved. Causal relations to weight gain and psychi-
atric symptoms as shown in the adult patient group, still need to be
established in adolescents. Taxa belonging to Lachnospiraceae help
predict shorter inpatient treatment duration and could be an interest-
ing candidate for future supplementation.
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